Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee examines 340B discounts and whether savings reach patients or raise employer costs
Summary
Senators and witnesses questioned whether the 340B drug discount program achieves its goal of making care affordable for low‑income patients, citing a study attributing multi‑billion dollar costs to employer‑sponsored insurance and recommending greater transparency or alternative funding mechanisms.
At the Senate HELP hearing, senators and witnesses raised concerns that the 340B drug discount program, created to help hospitals care for low‑income patients, may have unintended effects on commercial prices and employer costs unless the program is more transparent or better targeted.
Why it matters: Several witnesses told the committee that discounts captured by hospitals do not always flow to patients and that those discounts can create price incentives that affect employers…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
